UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (20313) 20313
Newsletter (3258) 3258
Magazine Article (191) 191
Newspaper Article (157) 157
Book Chapter (118) 118
Book / eBook (66) 66
Conference Proceeding (21) 21
Trade Publication Article (17) 17
Web Resource (14) 14
Publication (13) 13
Streaming Video (7) 7
Dissertation (4) 4
Reference (4) 4
Paper (2) 2
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (17280) 17280
science & technology (13100) 13100
life sciences & biomedicine (12901) 12901
thrombolytic therapy (10545) 10545
male (9272) 9272
female (8626) 8626
middle aged (7214) 7214
thrombolytic drugs (6958) 6958
aged (6684) 6684
cardiovascular system & cardiology (6031) 6031
myocardial infarction - drug therapy (5060) 5060
treatment outcome (4661) 4661
fibrinolytic agents - therapeutic use (4321) 4321
thrombolytic therapy - methods (4311) 4311
abridged index medicus (4055) 4055
tissue plasminogen activator - therapeutic use (3609) 3609
adult (3572) 3572
cardiac & cardiovascular systems (3545) 3545
stroke (3380) 3380
time factors (3210) 3210
neurosciences & neurology (3177) 3177
stroke - drug therapy (3126) 3126
peripheral vascular disease (3042) 3042
research (2933) 2933
thrombolysis (2709) 2709
clinical neurology (2614) 2614
risk factors (2517) 2517
aged, 80 and over (2476) 2476
care and treatment (2458) 2458
fibrinolytic agents - administration & dosage (2341) 2341
thrombolytic therapy - adverse effects (2252) 2252
general & internal medicine (2125) 2125
tissue plasminogen activator - administration & dosage (2059) 2059
drug therapy (1919) 1919
retrospective studies (1886) 1886
medicine, general & internal (1728) 1728
brain ischemia - drug therapy (1690) 1690
heart attack (1645) 1645
acute disease (1624) 1624
animals (1624) 1624
tissue plasminogen activator (1527) 1527
thrombosis (1454) 1454
prospective studies (1431) 1431
streptokinase - therapeutic use (1414) 1414
myocardial infarction - mortality (1393) 1393
fibrinolytic agents - adverse effects (1386) 1386
prognosis (1373) 1373
universities and colleges (1363) 1363
electrocardiography (1345) 1345
analysis (1323) 1323
myocardial infarction - therapy (1313) 1313
thrombosis - drug therapy (1311) 1311
anticoagulants - therapeutic use (1309) 1309
medical research (1296) 1296
health aspects (1279) 1279
surgery (1269) 1269
follow-up studies (1250) 1250
mortality (1154) 1154
heart attacks (1104) 1104
tissue plasminogen activator - adverse effects (1099) 1099
myocardial infarction - physiopathology (1068) 1068
drugs (1063) 1063
neurosciences (1063) 1063
ischemia (1048) 1048
pulmonary embolism - drug therapy (1022) 1022
anticoagulants (1006) 1006
myocardial infarction (1003) 1003
urokinase-type plasminogen activator - therapeutic use (1001) 1001
medicine, experimental (980) 980
infusions, intravenous (951) 951
hematology (950) 950
heparin - therapeutic use (945) 945
cardiology (941) 941
angioplasty, balloon, coronary (939) 939
usage (935) 935
recurrence (920) 920
tomography, x-ray computed (894) 894
drug therapy, combination (889) 889
myocardial infarction - diagnosis (876) 876
neurology (850) 850
randomized controlled trials as topic (843) 843
recombinant proteins - therapeutic use (837) 837
coronary angiography (829) 829
dosage and administration (795) 795
medicine & public health (792) 792
stroke - diagnosis (776) 776
platelet aggregation inhibitors - therapeutic use (768) 768
radiology, nuclear medicine & medical imaging (739) 739
pulmonary embolism (734) 734
risk assessment (732) 732
blood clot (719) 719
cardiac patients (704) 704
combined modality therapy (696) 696
hemorrhage (689) 689
clinical trials as topic (683) 683
plasminogen activators - therapeutic use (676) 676
patients (674) 674
cardiovascular (667) 667
fibrinolysis (660) 660
stroke - therapy (655) 655
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (43) 43
Online Resources - Online (16) 16
Collection Dvlpm't (Acquisitions) - Vendor file (6) 6
Collection Dvlpm't (Acquisitions) - Closed Orders (3) 3
Scarborough Hospital - General (2) 2
Lakeridge Health Sciences - Oshawa (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (22458) 22458
German (537) 537
French (272) 272
Japanese (239) 239
Spanish (208) 208
Italian (206) 206
Russian (192) 192
Chinese (169) 169
Portuguese (106) 106
Norwegian (86) 86
Danish (81) 81
Polish (70) 70
Swedish (65) 65
Czech (49) 49
Hungarian (43) 43
Dutch (34) 34
Turkish (17) 17
Finnish (16) 16
Serbian (16) 16
Slovak (15) 15
Hebrew (11) 11
Croatian (7) 7
Lithuanian (5) 5
Arabic (3) 3
Persian (3) 3
Romanian (3) 3
Slovenian (2) 2
Ukrainian (2) 2
Bulgarian (1) 1
Korean (1) 1
Latvian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Circulation (New York, N.Y.), ISSN 0009-7322, 09/2012, Volume 126, Issue 10, pp. 1185 - 1193
Background-Uncertainty remains over optimal antithrombotic treatment of patients with atrial fibrillation presenting with myocardial infarction and/or... 
atrial fibrillation | percutaneous coronary intervention | triple therapy | myocardial infarction | anticoagulants | antithrombotic treatment | hemorrhage | Cardiac & Cardiovascular Systems | Peripheral Vascular Disease | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Myocardial Infarction - mortality | Humans | Middle Aged | Acute Coronary Syndrome - mortality | Hemorrhage - mortality | Male | Hemorrhage - prevention & control | Angioplasty, Balloon, Coronary | Aspirin - administration & dosage | Fibrinolytic Agents - adverse effects | Myocardial Infarction - therapy | Drug Therapy, Combination - adverse effects | Vitamin K - antagonists & inhibitors | Aspirin - adverse effects | Atrial Fibrillation - mortality | Registries - statistics & numerical data | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Aged, 80 and over | Ticlopidine - administration & dosage | Female | Stroke - mortality | Platelet Aggregation Inhibitors - adverse effects | Atrial Fibrillation - drug therapy | Comorbidity | Risk Factors | Ticlopidine - analogs & derivatives | Acute Coronary Syndrome - drug therapy | Denmark - epidemiology | Aged | Fibrinolytic Agents - administration & dosage | Hemorrhage - chemically induced | Cohort Studies | Usage | Thrombolytic drugs | Research | Hemorrhage | Risk factors | Index Medicus | Abridged Index Medicus
Journal Article
Current drug targets, ISSN 1389-4501, 06/2012, Volume 13, Issue 7, pp. 917 - 924
Journal Article
The New England journal of medicine, ISSN 0028-4793, 02/2006, Volume 354, Issue 5, pp. 483 - 495
At present, 90 to 95 percent of percutaneous coronary interventions involve the implantation of a stent, often a drug-eluting stent, though most published data originated in the era of bare-metal stents... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Clinical trials | Heart attacks | Thrombolytic drugs | Drug therapy | Angioplasty | Coronary vessels
Journal Article
03/2020, Advances in Experimental Medicine and Biology, ISBN 9811525161, Volume 1177
.... Antithrombotic drugs permitted on the clinical currently can dramatically reduce major adverse cardiovascular events... 
Antithrombotic drugs | Thrombosis | Thrombolytic drugs | Fibrinolytic Agents - pharmacology | Hemorrhage - chemically induced | Thrombosis - prevention & control | Blood Coagulation - drug effects | Humans | Platelet Adhesiveness - drug effects
Book Chapter
Nature reviews. Drug discovery, ISSN 1474-1776, 2014, Volume 13, Issue 8, pp. 571 - 572
Journal Article
The New England journal of medicine, ISSN 1533-4406, 06/2016, Volume 374, Issue 24, pp. 2313 - 2323
Journal Article